Price target
6.380.000.00%
The 6 analysts offering 1 year price forecasts for GBM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to GBM in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GBM EPS for the last quarter is −0.52 EUR despite the estimation of −0.52 EUR. In the next quarter EPS is expected to reach −0.36 EUR. Track more of Inovio Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Inovio Pharmaceuticals, Inc. revenue is expected to reach 0.00 EUR. Check out Inovio Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, GBM price target is 6.38 EUR with a max estimate of 11.11 EUR and a min estimate of 1.54 EUR. Check if this forecast comes true in a year, meanwhile watch Inovio Pharmaceuticals, Inc. stock price chart and keep track of the current situation with GBM news and stock market news.
We've gathered opinions of 6 analysts rating GBM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.